Prediction of Week 4 Virological Response in Hepatitis C for Making Decision on Triple Therapy: The Optim Study

• Manuel Romero-Gómez ,

  * E-mail: mromerogomez@us.es

  Affiliation UCM Digestive Diseases & ciberehd, Valme University Hospital, Sevilla, Spain

  ⨯
• Juan Turnes,

  Affiliation Complejo Hospitalario de Pontevedra, Pontevedra, Spain

  ⨯
• Javier Ampuero,

  Affiliation UCM Digestive Diseases & ciberehd, Valme University Hospital, Sevilla, Spain

  ⨯
• Itziar Oyagüez,

  Affiliation Pharmacoeconomics & Outcomes Research Iberia, Madrid, Spain

  ⨯
• Beatriz Cuenca,

  Affiliation Hospital Infanta Cristina, Parla, Madrid, Spain

  ⨯
• Juan Gonzalez-Garcia,

  Affiliation Hospital Universitario La Paz, Madrid, Spain

  ⨯
• Belén Muñoz-Molina,

  Affiliation Unidad de Hepatología, Roche Farma, Spain

  ⨯
• Rocio Aguilar,

  Affiliation FISEVI, Sevilla, Spain

  ⨯
• Sandra Leal,

  Affiliation FISEVI, Sevilla, Spain

  ⨯
• Ramon Planas,

  Affiliation Hospital Germans Trias i Pujol & ciberehd, Badalona, Barcelona, Spain

  ⨯
• Javier Garcia-Samaniego,

  Affiliation Hospital Carlos III & ciberehd, Madrid, Spain

  ⨯
• Moises Diago,

  Affiliation Hospital General de Valencia, Valencia, Spain

  ⨯
• Javier Crespo,

  Affiliation Hospital Marqués de Valdecilla, Santander, Spain

  ⨯
• Jose Luis Calleja,

  Affiliation Hospital Puerta de Hierro, Madrid, Spain

  ⨯
• Miguel Angel Casado,

  Affiliation Pharmacoeconomics & Outcomes Research Iberia, Madrid, Spain

  ⨯
•  [ ... ],
• Ricard Sola

  Affiliation Hospital del Mar, IMIM, Barcelona, Spain

  ⨯
• [ view all ]
• [ view less ]